ARGX vs ISRG
argenx SE vs Intuitive Surgical — AI-powered side-by-side comparison
VS
ISRG
Intuitive Surgical
60
Buy
| Metric | ARGX | ISRG |
|---|
| AI Score |
67
|
60
|
| Price |
$1,019.71
|
$371.73
|
| P/E Ratio |
36.97×
|
42.21×
|
| ROE |
17.6%
|
16.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
89.9%
|
66.7%
|
| Debt / Equity |
0.01×
|
0.00×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
69.2
|
40.0
|
| Beta |
-0.022
|
1.46
|
| Expected Upside |
—
|
+18.5%
|
AI Committee View
Current Innellis committee reasoning for ARGX versus ISRG.
ARGX leads by 7 points.
ARGX scores 67/100 (Buy) versus ISRG at 60/100 (Buy).
ARGX Committee View
83% agreement
6 analysts
The primary driver is revenue growing 71.3% yoy -- genuine top-line momentum. The main limiting factor is price-to-book of 6.9x prices in significant intangible value. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 22.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 71.3% YoY -- genuine top-line momentum — Growth
- EPS growing 95.7% YoY — Growth
Bear Case
- Price-to-book of 6.9x prices in significant intangible value — Value
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Bollinger bandwidth of 32.9% signals elevated volatility — Risk
ISRG Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 45.2 is expensive by classic value standards — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical